These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6189134)
1. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374. III. Development of a radioimmunoassay and its application to the pharmacokinetics of ZK 36 374 in the rat. Krause W; Nieuweboer B Prostaglandins Leukot Med; 1983 Mar; 10(3):289-99. PubMed ID: 6189134 [TBL] [Abstract][Full Text] [Related]
2. Development of a radioimmunoassay and its application to the pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat. Krause W; Nieuweboer B Prostaglandins Leukot Med; 1984 Apr; 14(1):1-9. PubMed ID: 6374676 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the monkey (Macaca fascicularis). Krause W; Schubert M; Totzek M Prostaglandins Leukot Med; 1983 Jul; 11(3):325-38. PubMed ID: 6193537 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the beagle dog. Krause W Prostaglandins Leukot Med; 1984 Feb; 13(2):143-51. PubMed ID: 6201926 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat. Krause W; Schulze PE; Totzek M Prostaglandins Leukot Med; 1983 Jul; 11(3):241-57. PubMed ID: 6351102 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of the stable prostacyclin analogue, ZK 36 374, in the cat. Krause W; Beckmann R; Schubert M Prostaglandins Leukot Med; 1984 Aug; 15(2):187-97. PubMed ID: 6208562 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women. Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man. Krause W; Krais T Eur J Clin Pharmacol; 1986; 30(1):61-8. PubMed ID: 2423342 [TBL] [Abstract][Full Text] [Related]
9. Studies on the pharmacokinetics of ZK 96 480, a novel PGI2-mimetic, in rat and cynomolgus monkey. Hildebrand M Prostaglandins; 1986 Sep; 32(3):425-38. PubMed ID: 3538205 [TBL] [Abstract][Full Text] [Related]
10. Effects of new chemically and metabolically stable prostacyclin analogues (iloprost and ZK 96480) on early consequences of a transient cerebral oligemia, in the rat. Borzeix MG; Cahn R; Cahn J Prostaglandins; 1988 May; 35(5):653-64. PubMed ID: 2456591 [TBL] [Abstract][Full Text] [Related]
11. Evidence for high affinity prostacyclin binding sites in vascular tissue: radioligand studies with a chemically stable analogue. Rücker W; Schrör K Biochem Pharmacol; 1983 Aug; 32(16):2405-10. PubMed ID: 6193794 [TBL] [Abstract][Full Text] [Related]
12. Biotransformation of the stable prostacyclin analogue, iloprost, in the rat. Krause W; Hümpel M; Hoyer GA Drug Metab Dispos; 1984; 12(5):645-51. PubMed ID: 6209077 [TBL] [Abstract][Full Text] [Related]
13. Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals. Düsterberg B; Kühne G; Täuber U Arzneimittelforschung; 1986 Aug; 36(8):1187-90. PubMed ID: 3778555 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats. Casals-Stenzel J; Buse M; Losert W Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of iloprost and cicaprost in mice. Hildebrand M Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay for the chemical stable prostacyclin analog, 15AU81: a preliminary pharmacokinetics study in the dog. Findlay JW; McNulty MJ; Page TL; Chang SY; Sailstad JM Prostaglandins Leukot Essent Fatty Acids; 1993 Feb; 48(2):167-74. PubMed ID: 8446655 [TBL] [Abstract][Full Text] [Related]
17. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size. Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229 [TBL] [Abstract][Full Text] [Related]
18. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion. Ylikorkala D; Viinikka L Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375). Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328 [TBL] [Abstract][Full Text] [Related]
20. Bioactivation of eptaloprost in animals and man. Hildebrand M Prostaglandins; 1993 Aug; 46(2):177-89. PubMed ID: 7692471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]